EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Differential Therapeutic Modulations of Adiponectin: Beneficial, Adverse, and Context-Dependent Effects in Chronic Coronary Syndromes

Sanja Stojanović, Vladimir Petrović, Jasmina Jocić, Dejan Petrović, Miljana Šarac, Nemanja Nikolić, Dejan Simonović, Marija Marinković

Medical Principles and Practice · 29.05.2026 · 1-13

DOI: 10.1159/000552748 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Principles and Practice, online erschienen am 29.05.2026. Verfasst von Sanja Stojanović und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Treatment and Rehabilitation "Niška Banja", Niška Banja, Serbia, sanjastdr@gmail.com. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Different degrees of chronic metabolic inflammation and adiponectin resistance significantly contribute to the development of cardiovascular diseases and metabolic syndrome. Adiponectin is a unique pleiotropic adipokine with anti-inflammatory, antiatherogenic, and antidiabetic effects. In early metabolic dysfunction, adiponectin levels increase as a compensatory response, whereas in advanced coronary disease, hypoadiponectinemia develops due to adiponectin resistance. The aim of this review was to highlight how contemporary cardiovascular therapies alter adiponectin levels and why this is clinically important for reducing low-grade systemic and vascular inflammation in chronic coronary syndromes. Evidence suggests that drug classes such as peroxisome proliferator-activated receptor agonists, sodium-glucose transport proteins inhibitors, glucagon-like peptide-1 receptor agonists, renin-angiotensin-aldosterone system blockers, metformin, certain statins, and fibrates may increase adiponectin levels, although effects vary by drug class and disease stage. Although adiponectin represents a promising therapeutic target for the treatment of coronary syndromes, further experimental and pharmacological research is necessary to develop drugs based on its mechanism of action.

Schlagwörter

Stichwörter der Autor:innen

AdiponectinCardiovascular drugsChronic coronary syndrome

Autor:innen und Institutionen

  • Institute for Treatment and Rehabilitation "Niška Banja", Niška Banja, Serbia, sanjastdr@gmail.com.
  • Department of Histology and Embryology, Faculty of Medicine, University of Niš, Niš, Serbia.
  • Institute for Treatment and Rehabilitation "Niška Banja", Niška Banja, Serbia.
  • Polyclinic Nikolic, Niš, Serbia.
  • Emergency Center of the Niš, Clinic for Pulmonology, Niš, Serbia.

Zitieren

APA

Stojanović, S., Petrović, V., Jocić, J., Petrović, D., Šarac, M., Nikolić, N., Simonović, D., & Marinković, M. (2026). Differential Therapeutic Modulations of Adiponectin: Beneficial, Adverse, and Context-Dependent Effects in Chronic Coronary Syndromes. Medical Principles and Practice, 1-13. https://doi.org/10.1159/000552748

Vancouver

Stojanović S, Petrović V, Jocić J, Petrović D, Šarac M, Nikolić N, et al. Differential Therapeutic Modulations of Adiponectin: Beneficial, Adverse, and Context-Dependent Effects in Chronic Coronary Syndromes. Medical Principles and Practice. 2026:1-13. doi:10.1159/000552748

BibTeX
@article{Stojanovi2026,
  author = {Stojanović, Sanja and Petrović, Vladimir and Jocić, Jasmina and Petrović, Dejan and Šarac, Miljana and Nikolić, Nemanja and Simonović, Dejan and Marinković, Marija},
  title = {Differential Therapeutic Modulations of Adiponectin: Beneficial, Adverse, and Context-Dependent Effects in Chronic Coronary Syndromes},
  journal = {Medical Principles and Practice},
  year = {2026},
  pages = {1--13},
  doi = {10.1159/000552748}
}
Kostenlos starten →